C157H239N21O18 — CID 164954923
ethane;6-methylidene-3-(3-methyl-2-oxo-4-phenylimidazolidin-1-yl)piperidin-2-one;6-methylidene-3-(2-oxo-3-phenylimidazolidin-1-yl)piperidin-2-one;bis(6-methylidene-3-(2-oxo-4-phenyl-3-propan-2-ylimidazolidin-1-yl)piperidin-2-one);3-(6-methylidene-2-oxopiperidin-3-yl)-1,3-benzoxazol-2-one;1-(6-methylidene-2-oxopiperidin-3-yl)-3H-indol-2-one;3-(6-methylidene-2-oxopiperidin-3-yl)-5-phenyl-1,3-oxazolidin-2-one;6-methylidene-3-(2-oxo-3-propan-2-ylimidazol-1-yl)piperidin-2-one;pentakis(2-methylpropane) (PubChem CID 164954923) has the molecular formula C157H239N21O18 and a molecular weight of 2708.77 g/mol. Its IUPAC name is ethane;6-methylidene-3-(3-methyl-2-oxo-4-phenylimidazolidin-1-yl)piperidin-2-one;6-methylidene-3-(2-oxo-3-phenylimidazolidin-1-yl)piperidin-2-one;bis(6-methylidene-3-(2-oxo-4-phenyl-3-propan-2-ylimidazolidin-1-yl)piperidin-2-one);3-(6-methylidene-2-oxopiperidin-3-yl)-1,3-benzoxazol-2-one;1-(6-methylidene-2-oxopiperidin-3-yl)-3H-indol-2-one;3-(6-methylidene-2-oxopiperidin-3-yl)-5-phenyl-1,3-oxazolidin-2-one;6-methylidene-3-(2-oxo-3-propan-2-ylimidazol-1-yl)piperidin-2-one;pentakis(2-methylpropane).
| Compound Name | ethane;6-methylidene-3-(3-methyl-2-oxo-4-phenylimidazolidin-1-yl)piperidin-2-one;6-methylidene-3-(2-oxo-3-phenylimidazolidin-1-yl)piperidin-2-one;bis(6-methylidene-3-(2-oxo-4-phenyl-3-propan-2-ylimidazolidin-1-yl)piperidin-2-one);3-(6-methylidene-2-oxopiperidin-3-yl)-1,3-benzoxazol-2-one;1-(6-methylidene-2-oxopiperidin-3-yl)-3H-indol-2-one;3-(6-methylidene-2-oxopiperidin-3-yl)-5-phenyl-1,3-oxazolidin-2-one;6-methylidene-3-(2-oxo-3-propan-2-ylimidazol-1-yl)piperidin-2-one;pentakis(2-methylpropane) |
|---|---|
| PubChem CID | 164954923 |
| Molecular Formula | C157H239N21O18 |
| Molecular Weight | 2708.77 g/mol |
| Exact Mass | 2706.84 |
| IUPAC Name | ethane;6-methylidene-3-(3-methyl-2-oxo-4-phenylimidazolidin-1-yl)piperidin-2-one;6-methylidene-3-(2-oxo-3-phenylimidazolidin-1-yl)piperidin-2-one;bis(6-methylidene-3-(2-oxo-4-phenyl-3-propan-2-ylimidazolidin-1-yl)piperidin-2-one);3-(6-methylidene-2-oxopiperidin-3-yl)-1,3-benzoxazol-2-one;1-(6-methylidene-2-oxopiperidin-3-yl)-3H-indol-2-one;3-(6-methylidene-2-oxopiperidin-3-yl)-5-phenyl-1,3-oxazolidin-2-one;6-methylidene-3-(2-oxo-3-propan-2-ylimidazol-1-yl)piperidin-2-one;pentakis(2-methylpropane) |
| SMILES | C=C1CCC(N2C(=O)Cc3ccccc32)C(=O)N1.C=C1CCC(N2CC(c3ccccc3)N(C(C)C)C2=O)C(=O)N1.C=C1CCC(N2CC(c3ccccc3)N(C(C)C)C2=O)C(=O)N1.C=C1CCC(N2CC(c3ccccc3)N(C)C2=O)C(=O)N1.C=C1CCC(N2CC(c3ccccc3)OC2=O)C(=O)N1.C=C1CCC(N2CCN(c3ccccc3)C2=O)C(=O)N1.C=C1CCC(n2c(=O)oc3ccccc32)C(=O)N1.C=C1CCC(n2ccn(C(C)C)c2=O)C(=O)N1.CC.CC.CC.CC.CC.CC.CC.CC.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C |
| InChI | InChI=1S/2C18H23N3O2.C16H19N3O2.C15H17N3O2.C15H16N2O3.C14H14N2O2.C13H12N2O3.C12H17N3O2.5C4H10.8C2H6/c2*1-12(2)21-16(14-7-5-4-6-8-14)11-20(18(21)23)15-10-9-13(3)19-17(15)22;1-11-8-9-13(15(20)17-11)19-10-14(18(2)16(19)21)12-6-4-3-5-7-12;1-11-7-8-13(14(19)16-11)18-10-9-17(15(18)20)12-5-3-2-4-6-12;1-10-7-8-12(14(18)16-10)17-9-13(20-15(17)19)11-5-3-2-4-6-11;1-9-6-7-12(14(18)15-9)16-11-5-3-2-4-10(11)8-13(16)17;1-8-6-7-10(12(16)14-8)15-9-4-2-3-5-11(9)18-13(15)17;1-8(2)14-6-7-15(12(14)17)10-5-4-9(3)13-11(10)16;5*1-4(2)3;8*1-2/h2*4-8,12,15-16H,3,9-11H2,1-2H3,(H,19,22);3-7,13-14H,1,8-10H2,2H3,(H,17,20);2-6,13H,1,7-10H2,(H,16,19);2-6,12-13H,1,7-9H2,(H,16,18);2-5,12H,1,6-8H2,(H,15,18);2-5,10H,1,6-7H2,(H,14,16);6-8,10H,3-5H2,1-2H3,(H,13,16);5*4H,1-3H3;8*1-2H3 |
| InChIKey | BAXGGECDNIMICQ-UHFFFAOYSA-N |
| XLogP | 31.56 |
| TPSA | 438.92 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 196 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2708.77 |
| LogP ≤ 5 | 31.56 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 21 |